Clinical Trial Update: Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 study completed evaluating the safety of Depakote extended-release tablets in treating mania associated with bipolar disorder in children and adolesce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• DEPAKOTE ER (DIVALPROEX SODIUM)

Snippet

Sponsor: Abbott | Conditions: Bipolar I Disorder, Manic or Mixed | Phase 3 | Status: COMPLETED